Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis
- 1 September 1992
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 39 (1) , 30-34
- https://doi.org/10.1016/0306-9877(92)90136-z
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Increased blood clearance rate of indium-111 oxine-labeled autologous CD4+ blood cells in untreated patients with Hodgkin's diseaseBlood, 1990
- Commentary on ‘cellular, biochemical and functional effects of ozone: New research and perspectives on ozone health effects’Toxicology Letters, 1990
- Interleukin-1 induces interleukin-6 production in peripheral blood monocytesBlood, 1990
- Catabolism of therapeutic proteins and peptides with implications for drug deliveryAdvanced Drug Delivery Reviews, 1989
- Immunological Examinations in Patients with Chronic Conditions under Administration of Ozone/Oxygen MixturesOzone: Science & Engineering, 1989
- Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.The Journal of Immunology, 1989
- Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.The Journal of Immunology, 1988
- Administration of Interferon at Night May Increase its Therapeutic IndexCancer Drug Delivery, 1985